EXHIBIT 32.1
CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350/ SECURITIES EXCHANGE ACT RULE 13a-14(b), AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES – OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Cytori Therapeutics, Inc. for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report") Marc H. Hedrick, as President & Chief Executive Officer of Cytori Therapeutics, Inc., and Tiago Girão, as VP of Finance and Chief Financial Officer of Cytori Therapeutics, Inc., each hereby certifies, respectively, that:
1. | The Report that this certification accompanies fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934. |
2. | The information contained in the Report that this certification accompanies fairly presents, in all material respects, the financial condition and results of operations of Cytori Therapeutics, Inc. |
By: | /s/ Marc H. Hedrick, MD | |
Dated: March 24, 2016 | Marc H. Hedrick, MD | |
President & Chief Executive Officer | ||
By: | /s/ Tiago M. Girão | |
Dated: March 24, 2016 | Tiago M. Girão | |
VP of Finance and Chief Financial Officer |